Synageva BioPharma
About:
Synageva, a biopharmaceutical company, develops and commercializes novel, next generation and follow on protein therapeutics.
Website: http://www.synageva.com
Top Investors: New Leaf Venture Partners, Baker Brothers Advisors LLC, Tullis Health Investors, Kitty Hawk Capital, Cordova Ventures
Description:
Synageva is a biopharmaceutical company dedicated to developing and commercializing novel, next generation and follow on protein therapeutics that leverage the unique competitive advantages of their proprietary Synageva Expression Platform (SEPTM).
$597M
Waltham, Massachusetts, United States
1996-01-01
info(AT)synageva.com
Sanj K. Patel
251-500
2015-01-05
Delisted
© 2025 bioDAO.ai